Key result
Intracellular iron homeostasis and iron-dependent ferroptotic cell death play an essential role in doxorubicin-induced cardiotoxicity.
Why the study?
Doxorubicin clinical use is limited by severe dose-dependent cardiotoxicity, and recent discoveries show intracellular iron homeostasis plays an essential role in its mechanisms.
Answers are grounded in this paper and cite their sources.
Understanding the role of iron and ferroptosis in doxorubicin-induced cardiotoxicity may aid in developing novel drug delivery systems with reduced adverse effects.
As an anthracycline antibiotic, doxorubicin (DOX) is one of the most potent and widely used chemotherapeutic agents for treating various types of tumors. Unfortunately, the clinical application of this drug results in severe side effects, particularly dose-dependent cardiotoxicity. There are multiple mechanisms involved with the cardiotoxicity caused by DOX, among which intracellular iron homeostasis plays an essential role based on a recent discovery. In this mini-review, we summarize the clinical features and symptoms of DOX-dependent cardiotoxicity, discuss the correlation between iron and cardiotoxicity, and highlight the involvement of iron-dependent ferroptotic cell death therein. Recent advances in this topic will aid the development of novel DOX delivery systems with reduced adverse effects, and expand the clinical application of anthracycline.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2021) conducted a review in Doxorubicin-induced cardiotoxicity. Doxorubicin was evaluated. Intracellular iron homeostasis and iron-dependent ferroptotic cell death play an essential role in doxorubicin-induced cardiotoxicity.
Synapse has enriched 10 related papers. Consider them for comparative context: